U.S. FDA Launches Post-Market Safety Assessment of BHA

On February 11, 2026, the U.S. Food and Drug Administration (FDA) issued a Request for Information (RFI) seeking data on the current uses of butylated hydroxyanisole (BHA) in human food and food contact substances. This RFI marks the initiation of a comprehensive post-market assessment of BHA's safety in the U.S. food supply. Industry stakeholders are encouraged to submit relevant information within 60 days of the publication.